Home > Cashflow Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Net Cash Inflow / Outflow

    Back to Cashflow Statement
AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Cash Inflow / Outflow ₹799 Cr₹2,169 Cr₹-1,021 Cr₹223 Cr₹-1,164 Cr

What is the latest Net Cash Inflow / Outflow ratio of AUROBINDO PHARMA ?

The latest Net Cash Inflow / Outflow ratio of AUROBINDO PHARMA is ₹799 Cr based on Mar2026 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2026₹799 Cr
Mar2025₹2,169 Cr
Mar2024₹-1,021 Cr
Mar2023₹223 Cr
Mar2022₹-1,164 Cr

How is Net Cash Inflow / Outflow of AUROBINDO PHARMA Trending?

Years Net Cash Inflow / Outflow % Change
Mar2026 ₹799 Cr
-63.17
Mar2025 ₹2,169 Cr
Positive
Mar2024 ₹-1,021 Cr
Negative
Mar2023 ₹223 Cr
Positive
Mar2022 ₹-1,164 Cr -

Compare Net Cash Inflow / Outflow of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹95,516.4 Cr -2.5% 1.2% 48.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr 0.1% -5% 5.4% Stock Analytics
DIVIS LABORATORIES ₹244,762.0 Cr -1.7% 0.2% 39.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,448.0 Cr -2.5% -5.5% 30.2% Stock Analytics
CIPLA ₹107,043.0 Cr 0.9% -2.6% -14.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,820.0 Cr 0.1% 7.6% -3.5% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-2.5%

1.2%

48.2%

SENSEX

3.1%

1%

-9.1%


You may also like the below Video Courses